510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K233605Substantially Equivalent

ADVIA Centaur EBV-EBNA IgG

Biokit, S.A., Lliçà D’Amunt, Barcelona, ES / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)510(k) summary (opens on fda.gov)

K233605 is the FDA 510(k) clearance record for ADVIA Centaur EBV-EBNA IgG, a class I device, cleared for Biokit, S.A. on under FDA product code LLM (Test, Antigen, Nuclear, Epstein-Barr Virus). FDA records list 23 510(k) clearances for Biokit, S.A., from to . As of , FDA records show no recalls naming K233605.

Clearance record

Decision date
Received
(272 days to decision)
Product code
LLM Test, Antigen, Nuclear, Epstein-Barr Virus
Regulation
21 CFR 866.3235
Device class
Class I
Review panel
Microbiology
Applicant
Biokit, S.A. Av. Can Montcau, 7, Lliçà D’Amunt, Barcelona, ES
510(k) summary
Summary PDF
Third party review
No

Clearances, product code LLM

Trailing 12 months

FDA records hold no clearances under product code LLM in the trailing twelve months.

FDA records show no clearances under product code LLM in the twelve months to October 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code LLM, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260